Evidence map›Paper›PMID 39934154›Full record

ArticleScientific reports2025

Innovative application of ceftriaxone as a quorum sensing inhibitor in Pseudomonas aeruginosa.

Nourhan G Naga, Dalia E El-Badan, Mona E M Mabrouk, Heba S Rateb, Khaled M Ghanem, Mona I Shaaban

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Anti-QS Strategies AgainstMicroorganisms · 2025
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nourhan G NagaDepartment of Botany and Microbiology, Faculty of Science, Alexandria University, Alexandria, Egypt. nourhan.naga_pg@alexu.edu.eg.ORCID 0000-0001-7380-9116
Dalia E El-BadanDepartment of Botany and Microbiology, Faculty of Science, Alexandria University, Alexandria, Egypt.ORCID 0000-0002-1043-6954
Mona E M MabroukBotany and Microbiology Department, Faculty of Science, Damanhour University, Damanhour, Egypt.ORCID 0000-0002-9290-6816
Heba S RatebDepartment of Pharmaceutical and Medicinal Chemistry, Pharmacy College, Misr University for Science and Technology, Cairo, Egypt.ORCID 0000-0002-6952-1790
Khaled M GhanemDepartment of Botany and Microbiology, Faculty of Science, Alexandria University, Alexandria, Egypt.ORCID 0000-0001-6140-5026
Mona I ShaabanDepartment of Microbiology and Immunology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt. mona_ibrahem@mans.edu.eg.ORCID 0000-0003-3044-6102

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudomonas aeruginosa is a Gram-negative bacterium that has the potential to induce various healthcare-related infections through its array of virulence factors. The control of virulence factor expression is mainly regulated by a communication process among cells called quorum sensing (QS). Blocking QS could be a viable tactic to suppress virulence factors and reduce pathogenicity without impacting bacterial growth. This approach has the potential to significantly decrease the multiple drug resistance emergence. In this study, we explored the impact of ceftriaxone (CRO), which is a commonly used β-lactam antibiotic, and its metal derivatives on the QS system and virulence factors of both standard strains and clinical isolates of P. aeruginosa. The quorum sensing inhibitory (QSI) activity of CRO and ceftriaxone Nickel complex (CRON) was evaluated. The minimum inhibitory concentration (MIC) was determined and the effect of sub-MICs of CRO and CRON was assessed on P. aeruginosa strains virulence factors. CRO and CRON effectively suppressed the virulence factors of P. aeruginosa strains at sub-MICs, without altering bacterial viability. Additionally, a molecular docking investigation was carried out to identify potential mechanisms of QSI. CRO and CRON exhibited high ICM scores, potentially displacing natural ligands when interacting with LasR, LasI, and PqsR receptors.

Indexed as

Anti-Bacterial AgentsCeftriaxonePseudomonas aeruginosaQuorum SensingBacterial ProteinsMicrobial Sensitivity TestsMolecular Docking SimulationVirulence FactorsAnti-Bacterial AgentsBacterial ProteinsCeftriaxoneVirulence FactorsCeftriaxoneCeftriaxone derivativesPseudomonas aeruginosaQuorum sensing inhibitionVirulence factors

Identifiers

PMID39934154
PMCPMC11814147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.